Draper Asset Management, LLC Oramed Pharmaceuticals Inc. Call Options Transaction History

Draper Asset Management, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 02, 2023	SELL	$2.12 - $4.47 $1,696 - $3,576	-800 Reduced 5.06%	15,000 $53,000
Q1 2023 May 05, 2023	SELL	$1.93 - $13.1 $8,106 - $55,020	-4,200 Reduced 21.0%	15,800 $34,000
Q4 2022 Feb 08, 2023	BUY	$5.88 - $12.03 $117,600 - $240,600	20,000 New	20,000 $240,000

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $92M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Draper Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Draper Asset Management, LLC with notifications on news.